Engineering Characterization of Small-Scale Bioreactors for Large-Scale hiPSC Production

IF 3.1 3区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS
Pedro Vicente, Ana Meliciano, Cláudia Diniz, Artemis Charalambidou, Ana Paula Terrasso, Catarina Freitas, Andrea Ducci, Paula M. Alves, Martina Micheletti, António Roldão, Margarida Serra
{"title":"Engineering Characterization of Small-Scale Bioreactors for Large-Scale hiPSC Production","authors":"Pedro Vicente,&nbsp;Ana Meliciano,&nbsp;Cláudia Diniz,&nbsp;Artemis Charalambidou,&nbsp;Ana Paula Terrasso,&nbsp;Catarina Freitas,&nbsp;Andrea Ducci,&nbsp;Paula M. Alves,&nbsp;Martina Micheletti,&nbsp;António Roldão,&nbsp;Margarida Serra","doi":"10.1002/biot.70106","DOIUrl":null,"url":null,"abstract":"<p>Human induced pluripotent stem cells (hiPSC) have great potential for cell therapy applications. To meet the global demand for hiPSC-derived cell therapies, the implementation of scalable technologies, such as stirred-tank bioreactors (STB), is essential. However, the addition of physical cues, including shear stress, can impact cell viability and proliferation and requires precise tuning. In this work, we used an engineering characterization approach to estimate the impeller power number (0.5) and investigate the mixing and suspension dynamics in the first generation of small-scale (0.2 L) DASGIP bioreactors (DASGIP-STB). By keeping constant power input per volume (<i>P/V</i> = 4.6 W/m<sup>3</sup>) as a scale-up criteria, we successfully transferred a hiPSC expansion process to a 0.2 L single-use STB (BioBLU-STB) and scaled it up to a single-use 2 L STB (Univessel-STB) without compromising cell expansion, viability, and metabolism, as well as hiPSC quality attributes, including their pluripotent phenotype and differentiation potential.</p>","PeriodicalId":134,"journal":{"name":"Biotechnology Journal","volume":"20 9","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/epdf/10.1002/biot.70106","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Journal","FirstCategoryId":"5","ListUrlMain":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/biot.70106","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Human induced pluripotent stem cells (hiPSC) have great potential for cell therapy applications. To meet the global demand for hiPSC-derived cell therapies, the implementation of scalable technologies, such as stirred-tank bioreactors (STB), is essential. However, the addition of physical cues, including shear stress, can impact cell viability and proliferation and requires precise tuning. In this work, we used an engineering characterization approach to estimate the impeller power number (0.5) and investigate the mixing and suspension dynamics in the first generation of small-scale (0.2 L) DASGIP bioreactors (DASGIP-STB). By keeping constant power input per volume (P/V = 4.6 W/m3) as a scale-up criteria, we successfully transferred a hiPSC expansion process to a 0.2 L single-use STB (BioBLU-STB) and scaled it up to a single-use 2 L STB (Univessel-STB) without compromising cell expansion, viability, and metabolism, as well as hiPSC quality attributes, including their pluripotent phenotype and differentiation potential.

Abstract Image

Abstract Image

Abstract Image

Abstract Image

大规模生产hiPSC的小型生物反应器的工程特性
人诱导多能干细胞(hiPSC)在细胞治疗方面具有巨大的应用潜力。为了满足全球对hipsc衍生细胞疗法的需求,实施可扩展的技术,如搅拌槽生物反应器(STB)是必不可少的。然而,添加物理线索,包括剪切应力,可以影响细胞活力和增殖,需要精确调整。在这项工作中,我们使用工程表征方法来估计叶轮功率数(0.5),并研究了第一代小型(0.2 L) DASGIP生物反应器(DASGIP- stb)的混合和悬浮动力学。通过保持每体积恒定的功率输入(P/V = 4.6 W/m3)作为放大标准,我们成功地将hiPSC扩增过程转移到0.2 L一次性STB (BioBLU-STB),并将其扩展到一次性2l STB (Univessel-STB),而不影响细胞扩增,活力,代谢以及hiPSC质量属性,包括其多能表型和分化潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biotechnology Journal
Biotechnology Journal Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
2.10%
发文量
123
审稿时长
1.5 months
期刊介绍: Biotechnology Journal (2019 Journal Citation Reports: 3.543) is fully comprehensive in its scope and publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Some issues are devoted to a special topic, providing the latest information on the most crucial areas of research and technological advances. In addition to these special issues, the journal welcomes unsolicited submissions for primary research articles, such as Research Articles, Rapid Communications and Biotech Methods. BTJ also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author''s CV to the editorial office. BTJ promotes a special emphasis on: Systems Biotechnology Synthetic Biology and Metabolic Engineering Nanobiotechnology and Biomaterials Tissue engineering, Regenerative Medicine and Stem cells Gene Editing, Gene therapy and Immunotherapy Omics technologies Industrial Biotechnology, Biopharmaceuticals and Biocatalysis Bioprocess engineering and Downstream processing Plant Biotechnology Biosafety, Biotech Ethics, Science Communication Methods and Advances.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信